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Abstract
Human antibody response to the Anopheles gambiae salivary protein gSG6 has recently emerged as a potentially useful tool
for malaria epidemiological studies and for the evaluation of vector control interventions. However, the current
understanding of the host immune response to mosquito salivary proteins and of the possible crosstalk with early response
to Plasmodium parasites is still very limited. We report here the analysis of IgG1 and IgG4 subclasses among anti-gSG6 IgG
responders belonging to Mossi and Fulani from Burkina Faso, two ethnic groups which are known for their differential
humoral response to parasite antigens and for their different susceptibility to malaria. The IgG1 antibody response against
the gSG6 protein was comparable in the two groups. On the contrary, IgG4 titers were significantly higher in the Fulani
where, in addition, anti-gSG6 IgG4 antibodies appeared in younger children and the ratio IgG4/IgG1 stayed relatively stable
throughout adulthood. Both gSG6-specific IgG1 and IgG4 antibodies showed a tendency to decrease with age whereas, as
expected, the IgG response to the Plasmodium circumsporozoite protein (CSP) exhibited an opposite trend in the same
individuals. These observations are in line with the idea that the An. gambiae gSG6 salivary protein induces immune
tolerance, especially after intense and prolonged exposure as is the case for the area under study, suggesting that gSG6
may trigger in exposed individuals a Th2-oriented immune response.
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Introduction
The ability of hematophagous insects to feed on a protein-rich
source such as blood involves complex behavioral, morphological
and physiological adaptations to find suitable hosts, reach blood
vessels and to suck and digest blood. One of the results of these
adaptations to blood feeding was the evolution of repertoires of
salivary proteins playing crucial functions in counteracting the
hemostatic, inflammatory and immune responses of vertebrate
hosts to tissue injury [1]. These proteins, injected into the skin
during the blood meal, play essential roles in blood feeding but
also trigger an anti-saliva antibody response that can be exploited
as a tool to evaluate host exposure to disease vectors as diverse as
ticks [2], sandflies [3], triatomines [4], tsetse flies [5,6] and
mosquitoes [7–11]. Transcriptome studies during the last five to
ten years allowed to unravel the complexity of the salivary
repertoires of different mosquito species establishing that they
carry in their saliva around 70 to 130 salivary proteins [12–14].
Moreover, comparative analyses identified genus-specific proteins
and protein families, which are found for example in the saliva of
Anopheles mosquitoes but are absent in Aedes and Culex species, or
viceversa [15]. These genus-specific proteins, if immunogenic, may
represent ideal candidates for the development of sensitive, reliable
and reproducible serological tools for the evaluation of human
exposure to vectors of important human diseases such as malaria
or dengue.
Evaluation of malaria transmission and disease risk requires
both parasitological and entomological measurements, with the
latter classically based on the Entomological Inoculation Rate
(EIR) that is the number of infectious bites per person per unit of
time. However, determination of EIR can be difficult or
impossible in several epidemiological settings (low malaria
transmission, low or reduced vector density, logistic problems,
etc.) as well as in children (where assessment of Anopheles exposure
by human landing catches is ethically unfeasible). Thus, alternative
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tools would be extremely valuable. In this respect the Anopheles
gambiae gSG6 salivary protein appears a very promising tool for the
evaluation of human exposure to malaria vectors. gSG6 is a small
anopheline-specific protein which is exclusively expressed in adult
female salivary glands, it is relatively abundant in saliva and plays
a role in blood feeding [16,17]. Previous studies on populations
from Burkina Faso [18], Tanzania [19] and Uganda [20] showed
that human IgG response to the gSG6 protein is sufficiently short
lived to detect variation in exposure to malaria vectors both in
time and in space. Moreover, the anti-gSG6 IgG response to the
An. gambiae protein also reflects exposure to Anopheles arabiensis and
Anopheles funestus and, therefore, it may be considered as a reliable
indicator of human exposure to all three main Afrotropical
malaria vectors [21]. Using the gSG6-P1 peptide, which is
designed on the gSG6 protein, similar results were obtained by
Remoue and collaborators [22,23], who also showed it may be a
valuable tool to evaluate the efficacy of malaria vector control
interventions, such as the application of Insecticide Treated Nets
[24,25]. Considering that SG6 family members (i) are widespread
among anophelines (only exception so far appear to be Central
and South American species of the subgenus Nyssorhynchus) and (ii)
are well conserved in comparison to gSG6 (amino acid identity
from 52% with Anopheles dirus to 100% with members of the An.
gambiae complex) it is likely that the gSG6 protein may represent a
relevant indicator of human exposure to a wide range of
anopheline species.
We previously analyzed the response to the gSG6 protein in
Mossi and Fulani, two sympatric ethnic groups from a malaria
hyperendemic area of Burkina Faso. These two groups are known
for their different susceptibility to malaria, with the Fulani being
less parasitized, less affected by the disease and more responsive to
parasite antigens [26], possibly as a consequence of a functional
deficit of T regulatory cells (Treg) [27]. In our study the Fulani also
exhibited a higher IgG response to the An. gambiae salivary protein
gSG6. However, while a seasonal variation of the anti-gSG6 IgG
response was found in the Mossi, no significant difference between
high-transmission/rainy season and low-transmission/dry season
was observed in the Fulani [18]. Moreover, in both ethnic groups
the IgG response to the gSG6 antigen was higher in young
children and tended to decrease in adults, suggesting that the
intense and prolonged exposure to bites of anopheline mosquitoes
may induce immune tolerance toward this antigen [18]. We report
here the analysis of IgG1 and IgG4 subclasses among anti-gSG6
IgG responders of the Mossi and Fulani ethnic groups from
Burkina Faso.
Materials and Methods
2.1. Study Area and Subjects
The study was conducted in the villages of Barkoundouba and
Barkoumbilen, which are located at a five kilometers distance from
each other in a rural malaria hyperendemic area of Burkina Faso
(,35 kilometers NE of Ouagadougou). These two villages are
inhabited by two ethnic groups with different immune reactivity
and susceptibility to P. falciparum malaria, with the Fulani living in
Barkoundouba and the Mossi in Barkoumbilen [26]. The area is
characterized by intense P. falciparum transmission, especially
during the June–October rainy season (EIR.100/person/year).
Malaria prevalence is very high, and ,95% of malaria infections
are by P. falciparum. In the high transmission season infection rates
range from 60% to 90% (depending on age) in the Mossi-Rimaibe´
group, and from 20% to 80% amongst Fulani. Lower prevalence is
observed during the dry, low transmission season (40–80%
amongst Mossi and Rimaibe´ and 0–60% in Fulani). Sera were
collected during three cross-sectional surveys carried out at the
beginning (August 1994) and the end (October 1994) of the high-
transmission/rainy season, as well as during the following low-
transmission/dry season (March 1995). Plasmodium falciparum
inoculation rates were comparable in the two villages as previously
reported [28].
2.2. Ethics Statement
The study protocol was approved by the Technical Committee
of the Centre National de Lutte contre le Paludisme of the
Ministry of Health of Burkina Faso. Oral informed consent for
multiple immuno-parasitological, clinical and entomological sur-
veys was obtained from both the Fulani community living in
Barkoundouba and the Mossi community living in Barkoumbilen.
The samples utilized for this analysis have been collected in the
period from August 1994 to March 1995 in the frame of a larger
epidemiological study performed in Burkina Faso [26]. At that
time a national ethic committee was not yet in place and written
consent was not requested. Therefore, the study protocol and the
oral informed consent were approved by the Institutional Review
Board, i.e. by the Technical Committee of the Centre National de
Lutte contre le Paludisme of the Ministry of Health of Burkina
Faso. Individual oral consent was obtained from all adults and
from children’s parents or legal representatives. In June–July 1994,
prior to the start of the surveys, meetings were held in the villages
of the study area to explain, in the local languages, the objectives
of the study, the procedures involved and to answer questions from
the residents.
2.3. Entomological Data
Entomological measures were based on indoor pyrethrum spray
catches carried out monthly between August and November ‘94
and in March ‘95 (12 catches/month). In the study area the main
malaria vectors were An. gambiae, An. arabiensis and An. funestus, with
the members of the An. gambiae species complex (i.e. An. gambiae
and An. arabiensis) representing, on average, approximately 90% of
the indoor-resting Anopheles mosquitoes. The number of anophe-
les/person/night in the two villages under study has been
previously reported [18] and additional details on the study site
and parasitological aspects can be found elsewhere [26,28].
2.4. Plasma Samples
A total of 270 independent human sera (148 Mossi, 122 Fulani)
selected among anti-gSG6 IgG responders have been analyzed
here. These responders were identified in a previous study [18]
using as cut-off value for seropositivity the mean OD of unexposed
controls (sera from 60 Roman citizen) plus 3xSD. The collection
time, the number of individuals and ethnic group and the average
age in years 6 the 95% confidence interval (CI) were as follows.
August: 60 Mossi (22.064.5), 63 Fulani (16.163.9); October: 56
Mossi (13.063.4), 30 Fulani (21.267.0); March: 32 Mossi
(15.365.1), 29 Fulani (11.664.2). Sera from 44 Roman citizen
(1–81 years old, 33.167.1) who referred to a city hospital for
routine blood tests were used as control (unexposed individuals).
Data on IgG response to the P. falciparum circumsporozoite protein
(CSP) of the same 270 anti-gSG6 IgG responders and of 28
Roman citizen used as control were from a previous larger study
[26].
2.5. Enzyme-linked Immunosorbent Assays
ELISA was performed according to standard procedures. The
gSG6 protein was expressed and purified as previously described
[18]. Flat-bottom, 96-well plates (Nunc Maxisorp, M9410) were
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coated overnight with 50 ml of gSG6 at 10 mg/ml diluted in
coating buffer (15 mM Na2CO3, 35 mM NaHCO3, 3 mM NaN3,
pH 9.6). Wells were washed four times with PBST (0.05% Tween-
20 in 1x PBS), blocked for 3 hours at 25uC (150 ml 1% w/v
skimmed dry milk in PBST), washed again as above and incubated
overnight at 4uC with 50 ml of serum diluted 1:20. Plates were
then washed as above and incubated (3 hours, 25uC) with 100 ml
of sheep anti-human IgG1/HRP (Binding Site AP006) or 100 ml
of sheep anti-human IgG4/HRP (Binding Site AP009) both
diluted 1:1000 in blocking buffer. After washing the colorimetric
reaction was carried out with 100 ml of o-phenylenediamine
dihydrochloride (OPD, Sigma P8287; 15 min, 25uC in the dark).
Reactions were terminated by adding 25 ml of 2 M H2SO4.
OD492 were determined using a microplate reader (Biotek Synergy
HT).
IgG1 and IgG4 OD levels were converted to antibody titers
using standard curves set up as follows. As capturing factors goat
anti-human IgG (5 mg/ml; Jackson ImmunoResearch Laborato-
ries Inc, PA, USA) or mouse anti-human IgG4 (2 mg/ml; BD
Pharmingen, USA) were used for coating (50 ml coating buffer,
overnight at 4uC). After washing, blocking and washing again as
above wells were incubated overnight at 4uC with serial dilutions,
from 1 mg/ml to 0.0078 mg/ml (1 R 0.5 R 0.25 R 0.125 R
0.0625R 0.03125R 0.0156R 0.0078), of purified native human
IgG1 or IgG4 (ABD Serotec, Kidlington, Oxford, UK) in 50 ml of
blocking reagent. Incubation with anti-human IgG1/HRP or
IgG4/HRP and colorimetric detection were as described above.
The CSP IgG antibody response was evaluated with an ELISA kit
based on (NANP)40 antigen as previously described [26].
2.6. Data Analysis
IgG1 and IgG4 levels were determined by analyzing serum
samples in duplicate with the antigen and once without antigen
(coating buffer only). Final OD was calculated for each serum as
the mean OD value with antigen minus the OD value without
antigen. Serial dilutions of a pool of sera (1:6 R 1:18 R 1:54 R
1:162 R 1:486 R 1:1458 R 1:4376) were added to each plate as
standard curve to normalize experimental variability among
plates. Intra and inter assay variation of standard samples was
below 20%. Sera whose duplicates showed a coefficient of
variation .20% were not included into the analysis. Multiple
comparisons were performed by the Kruskal-Wallis test. Mann-
Whitney U test was used to compare IgG, IgG1 and IgG4 levels
among responders of two independent groups. The Wilcoxon
matched-pairs test was used for comparison of two paired groups.
Correlation was assessed by Spearman coefficient. All statistical
analyses were performed using GraphPad Prism 5.0 statistical
software (GraphPad Software Inc., La Jolla, CA).
Results
The IgG1 and IgG4 antibody response to the An. gambiae gSG6
protein was measured in 270 human sera collected in the villages
of Barkoundouba and Barkoumbilen, which are inhabited by the
Fulani and Mossi ethnic groups, respectively. Sera were collected
during three cross-sectional surveys, carried out at the beginning
(August) and the end (October) of the high-transmission/rainy
season as well as during the following low-transmission/dry season
(March), and they were selected among anti-gSG6 IgG responders
identified in a previous study [18]. As a comparison, data on the
IgG response to the P. falciparum CSP in the same 270 anti-gSG6
IgG responders were retrieved from a previous larger study [26].
EIR were comparable in the two villages as previously reported
[28], although the number of Anopheles/person/night, as measured
by the indoor pyrethrum spray catch method, was slightly higher
in Barkoundouba. Anyhow, a drop in anopheline density was
clearly evident in both villages during the dry season [18].
3.1. IgG1 and IgG4 Antibody Response to the An.
gambiae gSG6
When the anti-gSG6 IgG1 and IgG4 antibody titers were
compared among the different surveys, a seasonal variation
according to the high-transmission/rainy season was observed in
the Mossi (Kruskal-Wallis test: IgG1, p= 0.0004; IgG4,
p = 0.0030), whereas it was absent in the Fulani (Figure 1). More
specifically, in individuals from the Mossi ethnic group both IgG1
and IgG4 significantly decreased during the dry season (Mann-
Whitney U test, p#0.0005 and p#0.0045, respectively); on the
contrary, no significant differences were found in the Fulani,
although the median IgG4 value showed a peak at the end of the
transmission season (Figure 1). These observations are consistent
with previous findings showing seasonal variations of the anti-
gSG6 IgG response in the Mossi but no difference in the Fulani
[18].
The anti-gSG6 IgG1 antibody titers were comparable between
the two ethnic groups: only during the dry season, when the
antibody response drops among Mossi, IgG1 levels were higher in
the Fulani (Figure 1 and Table 1; Mann-Whitney U test,
p = 0.0200). On the contrary, median IgG4 levels were consis-
tently higher in the Fulani and this difference was significant in
August and March (Figure 1 and Table 1; Mann-Whitney U test,
p = 0.0206 and p,0.0001, respectively). Moreover, when the
IgG1 and IgG4 responses were compared in the same group of
individuals from the different surveys and ethnic groups anti-gSG6
IgG4 antibodies appeared as the dominant subclass in the Fulani;
instead, no difference was found in the Mossi where, furthermore,
median IgG4 titers were consistently lower than corresponding
IgG1 titers (Table 1).
3.2. IgG Response to the P. falciparum CSP Protein
We are also reporting here, as comparison, the IgG antibody
response to the P. falciparum CSP in the same group of anti-gSG6
IgG responders. As expected, the IgG response to CSP showed
seasonal variation in both ethnic groups (Kruskal-Wallis test:
Mossi p = 0.0203, Fulani p,0.0001) with a significant increase
during the transmission season (August vs October, Mann-
Whitney U test: Mossi p = 0.0076, Fulani p,0.0001) and a
decrease during the dry season that was significant in the Fulani
(October vs March, Mann-Whitney U test, p = 0.0002) (Figure 2).
Moreover, IgG levels were always higher in the Fulani as
compared to Mossi (Mann-Whitney U test: August p,0.0001,
October p,0.0001, March p=0.0236), a result fully consistent
with what previously reported [26]. No correlation was found
between the IgG response to the CSP, which is supposed to denote
exposure to Plasmodium sporozoites (i.e. to infectious mosquito
bites), and IgG1 or IgG4 responses to the gSG6 salivary protein,
which is expected to reflect overall mosquito exposure.
3.3. Humoral Response to the gSG6 and CSP Proteins
According to Age
In a previous investigation on a larger set of samples including
the ones analyzed here we found, both in the Fulani and in the
Mossi, a progressive decrease with age of the anti-gSG6 IgG
response [18]. When the subset of IgG responders studied here
was sorted in five different age groups (1–5, 5–10, 10–20, 20–40
and .40 years old) we observed a similar situation for the IgG1
and IgG4 responses to gSG6. As a general trend, median levels of
IgG1 and IgG4 Antibody Response to the Anopheles gSG6 Salivary Protein
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gSG6-specific IgG1 and IgG4 antibodies appeared to decrease
with age progression: this applied both to Mossi and to Fulani,
although statistical support was only obtained for the August
survey (not shown), perhaps also because of its slightly larger and
better balanced sample size. However, when data from the three
surveys were pooled and analyzed together, the age decrease was
statistically significant in Mossi and Fulani both for IgG1 and IgG4
(Kruskal-Wallis, 0.0144$p$0.0011, Figure 3), although with a
slightly different pattern in the two ethnic groups. Actually,
median IgG1 titers had their peaks in 1–5 years old children in
both groups (Figure 3A–B), whereas median IgG4 titer also peaked
in young children in the Fulani but later, at 5–10 years of age, in
the Mossi (Figure 3C–D). The pattern appeared even more clear
looking at the IgG4/IgG1 ratio, with comparable values among
the five age groups in the Fulani and a significant difference in the
Mossi (Figure 4; Kruskal-Wallis, p = 0.0005). At 1–5 years of age
the ratio was significantly higher in the Fulani as compared to the
Mossi (median values: Mossi 0.35; Fulani 1.93; Mann-Whitney U
test, p = 0.0019), whereas no difference was found between the two
tribes in 5–10 years old children (median values: Mossi 5.40;
Fulani 3.60). These observations suggest that the humoral
response to the gSG6 salivary protein involves a switch from
IgG1 to IgG4 which takes place earlier in the Fulani (before 5
years of age) and only later in the Mossi (in 5–10 years old
children). After 10 years of age the ratio IgG4/IgG1 decreases
slightly in the Fulani but drops significantly in the Mossi (Mann-
Whitney U test, p = 0.0012) and in 10–20 years old individuals the
ratio appears again significantly higher in the Fulani (median
values: Mossi 0.50; Fulani 1.61; Mann-Whitney U test,
p = 0.0259). After reaching the age of twenty the IgG4/IgG1
ratio does not seem to change significantly anymore in the two
ethnic groups, although it should be noted that in the last age
groups the lower sample size makes the statistical analysis less
robust.
As expected the response to the P. falciparum CSP follows the
typical pattern already known for this and other parasite antigens,
i.e. an increase from childhood to adulthood, with a slight decrease
in elderly people in both ethnic groups (Figure 3E–F). The
different trend in the response to the mosquito gSG6 and to the
parasite CSP antigens is well summarized by the scatter plot
shown in Figure 5 where the anti-gSG6 IgG1 and IgG4 titers and
the anti-CSP IgG response are reported in function of age. The
Figure 1. Seasonal variation of the gSG6-specific IgG1 and IgG4 antibody titers in the sympatric ethnic groups Mossi and Fulani.
Scatter plots reporting IgG1 (left panel) and IgG4 (right panel) antibody titers among gSG6 IgG responders of the Mossi and Fulani ethnic groups in
the three different surveys. C, unexposed controls. Bars indicate median values. Number of individuals analyzed (n) and average age in years695% CI
were as follows. August: Mossi n = 60 (22.064.5), Fulani n = 63 (16.163.9); October: Mossi n = 56 (13.063.4), Fulani n = 30 (21.267.0); March: Mossi
n = 32 (15.365.1), Fulani n = 29 (11.664.2); Controls n = 44 (33.167.1). P values determined according to the Kruskal-Wallis test. Pairwise comparisons
refer to the Mann-Whitney U test (*, 0.01,p,0.05; **, 0.001,p,0.01; ***, p,0.001). Note that one (left panel) and twenty-six (right panel) data
points are outside the axis limits.
doi:10.1371/journal.pone.0096130.g001
Table 1. Comparison of the gSG6-specific IgG1 and IgG4 antibody titers in individuals of the Mossi and Fulani ethnic groups in the
different surveys.
Survey Group1 IgG12 IgG42 P-value3
Aug ‘94 M 11.49 (3.88–20.97) 5.56 (0.98–24.32) ns
Oct ‘94 M 11.80 (4.24–32.31) 8.25 (1.45–54.37) ns
Mar ‘95 M 3.53 (0.00–6.24) 1.12 (0.00–5.55) ns
Aug ‘94 F 10.18 (2.16–27.04) 17.24 (2.99–58.96) ***
Oct ‘94 F 10.87 (0.48–22.45) 48.88 (0.42–108.80) ***
Mar ‘95 F 10.79 (0.70–20.40) 19.86 (6.30–58.80) **
- C 0.00 (0.00–0.00) 0.00 (0.00–0.00) ns
(1). M. Mossi; F, Fulani; C, Controls.
(2). Median antibody titer (ng/ml); 25th–75th percentiles are given in parentheses.
(3). Pairwise comparison by the Wilcoxon matched-pairs signed rank test. Number of individuals, average age and asterisks as in Figure 1.
doi:10.1371/journal.pone.0096130.t001
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best-fit lines show the strong correlation with age of the IgG
response to CSP (Mossi: Spearman r= 0.53, p,0.0001; Fulani:
r = 0.41, p,0.0001), whereas an inverse correlation was found in
both ethnic groups for the IgG1 (Mossi: r =20.25, p = 0.0019;
Fulani: r =20.27, p = 0.0024) and IgG4 (Mossi: r =20.12,
p = 0.1359; Fulani: r =20.29, p= 0.0013) responses to gSG6.
Moreover, the trends depicted by the best-fit lines in Figure 5 show
that, independently from the age, the IgG1 response to gSG6 is
similar in the two tribes whereas both the anti-gSG6 IgG4
response and the IgG response to CSP are higher in the Fulani.
Discussion
We measured the anti-gSG6 IgG1 and IgG4 antibody levels in
the sympatric ethnic groups Mossi and Fulani and found that IgG1
and IgG4 titers were high during the rainy season and decreased
during the dry season in the Mossi. This was not surprising since a
change of gSG6-specific IgG antibody levels according to malaria
transmission and vector density was also observed in individuals of
the less protected Mossi group in a previous study [18]. Moreover,
similar seasonal variations of IgG1 and IgG4 response to mosquito
saliva were previously reported in a Finnish group exposed to Aedes
communis [29]. By contrast no seasonal variation of the anti-gSG6
IgG1 and IgG4 antibody titers was observed in individuals of the
more protected Fulani group. We hypothesized that the higher
baseline level of immunity in the Fulani may mask any temporal
variations of the anti-gSG6 humoral response and the results
reported here seem to further support this interpretation.
Individuals of the Fulani ethnic group were previously found to
carry higher titers of circulating IgG antibodies against the salivary
protein gSG6 as compared to Mossi [18]. Here the two tribes
showed very similar titers of anti-gSG6 IgG1 antibodies during the
rainy season; only during the dry season, when titers dropped in
the Mossi while they stayed essentially unchanged in the Fulani,
IgG1 levels were higher in the latter. A different pattern was found
for IgG4 antibodies: in all the surveys median anti-gSG6 IgG4
titers were higher in the Fulani and the difference was significant
both during the rainy (August) and the dry (March) periods.
Human IgG response to mosquito bites is known for being mainly
characterized by saliva-specific antibodies of the IgG1 and IgG4
subclasses [35–37]. We do not know if the gSG6 protein may also
evoke high levels of IgG2 and IgG3 antibodies, nevertheless the
observations reported here suggest that IgG4 antibodies may
account for most of the difference in the anti-gSG6 IgG response
between these two ethnic groups. We should emphasize here that,
although exposure to Anopheles mosquitoes was rather high in both
villages during the transmission season (from 6.361.5 to
21.8610.3 Anopheles/person/night in the period August–October),
vector density was slightly higher in Barkoundouba, which is
inhabited by the Fulani [18]. Moreover, it may be argued that also
known behavioral differences such as cattle herding or guarding
may potentially result in higher exposure of Fulani to outdoor
biting as compared to Mossi. For these reasons we cannot rule out
the possibility that a difference in mosquito biting rates may
contribute to the higher anti-gSG6 IgG4 titers reported here.
Nevertheless, our findings suggest that the genetic diversity
between Fulani and Mossi is playing a key role in their different
immune response to mosquito salivary antigens, which is fully
consistent with the different response of these two ethnic groups to
malaria antigens [26,27,30–34]. In this respect, earlier studies on
the response to parasite antigens of Mossi and Fulani, either from
Mali or from Burkina Faso, showed that IgG4 titers were usually
very low with IgG1 and IgG3 being the dominant IgG subclasses
[30–32]. Only one study reported higher IgG4 titers against the P.
falciparum 3D7-MSP2 allele in a Fulani group from Eastern Sudan
as compared to non-Fulani neighbors [34]. We found here high
levels of IgG4 antibodies against the gSG6 protein in both groups,
with IgG4 titers higher in the Fulani than in the Mossi. Moreover,
in the Fulani IgG4 titers were significantly higher than IgG1 titers
in all the surveys, pointing to IgG4 as the dominant circulating
antibody subclass against the gSG6 protein; this was not the case
for the Mossi where no difference between anti-gSG6 IgG4 and
IgG1 titers was found.
High levels of antigen-specific IgG4 are most likely associated to
the continued exposure of the population under study to Anopheles
saliva and, perhaps, to allergen-like properties of the gSG6
protein. Moreover, the increase of the anti-gSG6 IgG4/IgG1 ratio
may be related to the development of tolerance to mosquito
salivary components. Indeed it is known since the mid-twentieth
century that intense, repeated and prolonged exposure to
mosquito bites may induce desensitization, with disappearance
of immediate and delayed cutaneous reactions [38–40]. Further-
more, earlier longitudinal studies on beekepers clearly showed that
prolonged exposure to honey bee venom induces a shift in the
lgG4/lgG1 antibody ratio. Indeed, in novice beekeepers IgG
antibodies to phospholipase A2 (PLA2) are predominantly of the
IgG1 subclass; however, the relative contribution of lgG4 to total
anti-PLA2 IgG response increases with time and virtually all
beekeepers with an history of exposure of more than 3 years
exhibit an anti-PLA2 IgG4-dominated response [41]. Similarly,
higher levels of food-specific IgG4 have been associated with
tolerance in food atopic children [42,43].
It has been previously suggested that the age decrease of the
anti-gSG6 IgG response may be ascribed to the development of
immune tolerance [18]. The shift of the anti-gSG6 IgG4/IgG1
antibody ratio found here fully supports the idea that the
continued and intense exposure to Anopheles bites induces
desensitization to mosquito salivary components in the population
under study. As mentioned above for beekepers, allergen-specific
IgG4 usually appear only after prolonged immunization and their
presence is considered as a sign of activation of anti-inflammatory
and tolerance-inducing mechanisms [44]. Accordingly, the
appearance of allergen-specific IgG4 antibodies has usually a
protective effect and is associated with an improvement in allergic
Figure 2. Seasonal variation of the IgG response to the P.
falciparum CSP in Mossi and Fulani. Scatter plot of OD values
representing the IgG response to the P. falciparum CSP among gSG6
IgG responders of the Mossi and Fulani ethnic groups in the three
different surveys. C, unexposed controls (n = 28). Bars, number of Mossi
and Fulani analyzed, p values and pairwise comparisons as in Figure 1.
Note that three data points are outside the axis limits.
doi:10.1371/journal.pone.0096130.g002
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Figure 3. Distribution of anti-gSG6 IgG1 and IgG4 and of anti-CSP IgG in Mossi and Fulani according to different age groups. Box
plots showing IgG1 and IgG4 response to gSG6 (A-D) and IgG response to CSP (E-F) among gSG6 IgG responders from the three different surveys.
Boxes display median values, 25th and 75th percentiles. Whiskers represent 5–95 percentiles and dots the outliers. Anti-gSG6 IgG1 and IgG4 antibody
titers are expressed in ng/ml, anti-CSP IgG levels as OD405. The five different age groups (years) are indicated at the bottom. Data from the three
different surveys were pooled and the number of individuals for each age group is given in parenthesis. Left panels (A, C, E) refer to Mossi and right
panels (B, D, F) to Fulani as indicated. P values were determined by the Kruskal-Wallis test and pairwise comparisons were according to Mann-Whitney
U test (*, 0.01,p,0.05; **, 0.001,p,0.01; ***, p,0.001).
doi:10.1371/journal.pone.0096130.g003
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symptoms, most likely due to their capacity to compete for allergen
binding with cell surface-bound IgE, which prevents activation of
mast cells and inhibits antigen-presenting cells [45]. The
mechanisms inducing tolerance against mosquito bites are
presently not fully understood but are likely to involve Treg cells,
which play a key role in maintenance of immune tolerance and
down-regulation of inflammatory responses, also through their
secretion of IL-10 and TGF-b [46]. IL-10 in particular affects class
switch and enhances IgG4 production [44,45] suggesting a
possible involvement of IL-10-producing Treg cells in the immune
response to the gSG6 antigen. Indeed a higher frequency of CD4+
CD25+ IL-10-secreting cells was recently reported in the Fulani
ethnic group as compared to Mossi in the same area of Burkina
Faso [47], although in a previous study similar levels of IL-10 were
found in the sera of 58 Fulani and 82 Mossi collected during the
same August 1994 survey from the Barkoundouba area analyzed
here [27].
Taken together our data show that the gSG6 antigen carried in
the saliva of anopheline mosquitoes induces in exposed individuals
a T helper type 2 immune response with production of IgG1 and
IgG4 antibodies. Moreover, the intense and prolonged exposure to
Anopheles bites induces the activation of mechanisms of immune
tolerance with antibody class switch and production of high levels
of IgG4. Further studies will be needed to elucidate the
mechanisms determining both higher levels of circulating anti-
gSG6 IgG4 antibodies and the earlier switch from IgG1 to IgG4
observed in individuals of the Fulani ethnic group. In conclusion
the study reported here on the An. gambiae gSG6 represents a first
step toward a better understanding of the human immune
response to mosquito salivary proteins, a subject which would
deserve more attention, especially considering that mosquitoes are
vectors of devastating viral and parasitic diseases and that these
pathogens are transmitted and exposed to the human immune
system in the context of mosquito saliva.
Figure 4. IgG4/IgG1 ratio by age group in Mossi and Fulani. Scatter plot reporting the IgG4/IgG1 ratio by age group in Mossi (n = 120) and
Fulani (n = 95). Data from the three different surveys were pooled together and individuals with no detectable IgG1 or IgG4 (or both) were excluded
from the analysis. The five different age groups (years) are indicated at the bottom. The number of individuals for each age group is given in
parenthesis. Bars indicate median values. P values determined according to the Kruskal-Wallis test. Pairwise comparisons refer to the Mann-Whitney U
test (*, 0.01,p,0.05; **, 0.001,p,0.01; ***, p,0.001). Note that twenty data points are outside the axis limits.
doi:10.1371/journal.pone.0096130.g004
Figure 5. Humoral response to the gSG6 and CSP proteins according to age. Scatter plot reporting the antibody responses to gSG6 (IgG1,
black; IgG4, red) and to CSP (IgG, green) as function of age among gSG6 IgG responders of the Mossi (n = 148) and Fulani (n = 122) ethnic groups from
the three different surveys. Anti-gSG6 IgG1 and IgG4 are expressed as titers (ng/ml, left Y axis); IgG response to CSP is expressed as OD405 (right Y
axis). The best-fit lines are shown (Mossi, solid lines; Fulani dashed lines). Spearman correlation coefficients: (i) anti-CSP IgG (Mossi, r = 0.53, p,0.0001;
Fulani, r = 0.41, p,0.0001); (ii) anti-gSG6 IgG1 (Mossi, r =20.25, p = 0.0019; Fulani, r =20.27, p = 0.0024); (iii) anti-gSG6 IgG4 (Mossi, r =20.12,
p = 0.1359; Fulani, r =20.29, p = 0.0013). Note that twenty-six data points are outside the axis limits.
doi:10.1371/journal.pone.0096130.g005
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